Qingxi Meng

Qingxi Meng

Auto-generated profile, based on publicly available information

Qingxi Meng

Department of Orthopedics

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2015 in Medicine
Verified
Journal Article
Open access
QMQingxi Meng
Qingxi Meng
JYJi Yue
Ji Yue
MSMingfu Shang
Mingfu Shang
QSQunqun Shan
Qunqun Shan
JQJian Qi
Jian Qi
WWWeiguo Wang
Weiguo Wang
Single nucleotide polymorphisms (SNPs) at the glucose transporter 9 (GLUT9) locus are clearly related to uric acid concentrations previously identified as a major cause of gout. Due to the important function of various SNPs, we hypothesized that the common GLUT9 polymorphisms (rs16890979, rs6855911, and rs7442295) are associated with gout risk. The purpose of this investigation was to test the hypothesis.Gout risk was estimated by calculating odds ratios and 95% confidence intervals (ORs and 95% CIs). Either the fixed- or the random-effect model was used for OR calculations. Subgroup analyses were carried out by ethnicity for rs16890979 and by gender for all SNPs.We analyzed a total of 8 studies involving 2525 subjects for rs16890979, 2654 for rs6855911, and 2637 for rs7442295. A significantly declined risk was suggested in the meta-analyses of rs16890979 under dominant model (OR = 0.44, 95% CI = 0.34-0.58) and heterozygote model (OR = 0.44, 95% CI = 0.33-0.59). The OR was 0.41 under allele frequency model (OR = 0.41, 95% CI = 0.33-0.53). Significantly declined risk in relation to rs16890979 was also found among Asians. Similarly decreased risk was revealed for rs7442295, both in total samples and in males. However, the meta-analysis of rs6855911 revealed no significant associations.These data seem to support the hypothesis that the risk of gout may be associated with GLUT9 rs16890979 and rs7442295.

1 January 2021 in BioMed Research International
Verified
Journal Article
Open access
PDF file
QSQunqun Shan
Qunqun Shan
NLNing Li
Ning Li
FZFan Zhang
Fan Zhang
PYPeng Yu
Peng Yu
QMQingxi Meng
Qingxi Meng
During disc degeneration, the increase of inflammatory cytokines and decrease of disc cell density are two prominent features. Enhanced inflammatory reaction contributes to disc annulus fibrosus (AF) cell apoptosis. In this study, we investigated whether resveratrol can suppress AF cell apoptosis in an inflammatory environment. Rat disc AF cells were cultured in medium with or without tumor necrosis factor‐α (TNF‐α). Resveratrol was added along with the culture medium supplemented with TNF‐α. Caspase‐3 activity, cell apoptosis ratio, expression of apoptosis‐associated molecules (Bcl‐2, Bax, caspase‐3, cleaved PARP, and cleaved caspase‐3), reactive oxygen species (ROS) content, and the total superoxide dismutase (SOD) activity were measured. Our results showed that TNF‐α significantly increased caspase‐3 activity and AF cell apoptosis ratio and upregulated gene/protein expression of Bax, caspase‐3, cleaved caspase‐3, and cleaved PARP, whereas it downregulated the expression of Bcl‐2. Moreover, TNF‐α significantly increased ROS content but decreased the total SOD activity. Further analysis demonstrated that resveratrol partly attenuated the effects of TNF‐α on AF cell apoptosis‐associated parameters, decreased ROS content, and increased the total SOD activity in the AF cells treated with TNF‐α. In conclusion, resveratrol attenuates inflammatory cytokine TNF‐α‐induced AF cell apoptosis through regulating oxidative stress reaction in vitro. This study sheds a new light on the protective role of resveratrol in alleviating disc degeneration.